A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.

NCT03845387 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: KDT-3594
DRUG: Pramipexole

Sponsor

Kissei Pharmaceutical Co., Ltd.